Safety and efficacy of crizotinib in patients with non-small cell lung cancer
Latest Information Update: 23 Dec 2020
At a glance
- Drugs Crizotinib (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 23 Dec 2020 New trial record